Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Reexamination Certificate
2000-07-28
2002-01-29
Navarro, Mark (Department: 1645)
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
C435S320100, C435S325000, C536S023700
Reexamination Certificate
active
06342385
ABSTRACT:
FIELD OF THE INVENTION
The invention relates to polypeptide antibiotics and to the identification of genetic loci associated with expression of the antibiotics. The invention particularly describes a purified lanthionine-containing antimicrobial agent, DNA encoding the protein, and methods and compositions for treatments employing the antibiotic.
BACKGROUND OF THE INVENTION
Several species of bacteria inhabit the human oral cavity; among them
Streptococcus mutans
is considered a major etiologic agent responsible for dental caries. Loesche (1986)
Microbiol. Rev.
50:353-380. Previous studies showed a certain percentage of clinical isolates of
S. mutans
producing antimicrobial substances called mutacins. Caufield et al. (1985)
Infect. Immun.
48:51-56; Hamada et al. (1975)
Arch. Oral Biol.
20:641-648. Mutacins are active against closely related species as well as a surprisingly wide spectrum of other Gram-positive bacteria. Parrot et al. (1990)
Can. J Microbiol.
36:123-130. The ability to produce mutacins, combined with lactic acid production by
S. mutans
may contribute to the pathogenesis of these bacteria. Kleinberg, p. 605-624, in W. A. Nolte (ed.), Oral microbiology, The C.V. Mosby Company, St. Louis. Production of mutacins by
S. mutans
and other oral streptococci may also play a protective role to the host against pathogens such as Group A streptococci and
Streptococcus pneumoniae
. In this respect, mutacins may serve as antimicrobial agents in the future.
Lantibiotics are lanthionine-containing small peptide antibiotics that are produced by gram-positive bacteria. Jung (ed.), p. 1-34, in G. Jung and H. G. Sahl (ed.), Nisin and novel lantibiotics, ESCOM Sci. Publ., Leiden; Sahl et al. (1995)
Eur. J. Biochem.
230:827-853. The lantibiotics are ribosomally synthesized and post-translationally modified. The modification reactions include dehydration of serine and threonine residues and the addition of thiol groups from cycteine residues to the double bound to form lanthionines and &bgr;-methyllanthiones, respectively. Some dehydrated serine or threonine may remain as such in the mature lantibiotic molecule.
Based on the secondary structures, Jung assigned lantibiotics into two classes, Type-A (linear) and Type-B (globular). Jung (ed.), p. 1-34, in G. Jung and H. G. Sahl (ed.), Nisin and novel lantibiotics, ESCOM Sci. Publ., Leiden. de Vos et al. ((1995)
Molecular Microbiol.
17:427-437) and Sahl and Bierbaum (Sahl et al. (1998)
Annu. Rev. Microbiol.
52:41-79) further divided each class into subgroups according to their primary peptide sequences. Thus, subgroup AI contains the nisin-like lantibiotics with nisin, subtilin, epidermin and pep5 as the most thoroughly characterized members. Allgaier et al. (1986)
Eur. J. Biochem.
160:9-22; Gross et al. (1968)
FEBS Lett
2:61-64; Gross et al. (1971)
J Am. Chem. Soc.
93:4634-4635; Kaletta et al. (1989)
Arch. Microbiol.
152:16-19; Weil et al. (1990)
Eur. J. Biochem.
194:217-223. Subgroup AII consists of lacticin 481, SA-FF22, salivaricin and variacin. Hynes et al. (1993)
Appl. Environ. Microbiol.
59:1969-1971; Piard et al. (1993)
J. Biol. Chem.
268:16361-16368; Pridmore et al. (1996)
Appl. Environ, Microbiol.
62:1799-1802; Ross et al. (1993)
Appl. Environ. Microbiol.
59:2014-2021. The genes responsible for the biosynthesis of the lantibiotics are organized in operon-like structures. The biosynthesis locus of all members in the subgroup AI lantibiotics consists of lanA, the structural gene for the lantibiotic; lanB and lanC, the modifying enzyme genes for post-translational modification of the preprolantibiotic; lanP, the protease gene for processing of the prelantibiotic; and lanT, the ABC transporter for secretion of the lantibiotic. In addition, epidermin and gallidennin have an extra gene, lanD, which is responsible for the C-terminal oxidative decarboxylation of the lantibiotic. Kupke et al. (1994)
J. Biol. Chem.
269:5653-5659; Kupke et al. (1995)
J. Biol Chem.
270:11282-89. In comparison, subgroup AII lantibiotics have simpler genomic organizations. In subgroup AII, lanB and lanC are combined into one gene, lanM, and lanP and lanT are combined into lanT. Chen et al. (1999)
Appl. Environ. Microbiol.
65:1356-1360; Qi et al. (1999)
Appl Environ. Microbiol
65:652-658; Rince et al. (1994)
Appl. Environ. Microbiol.
60:1652-1657. All lantibiotic loci also contain a set of immunity genes, which are responsible for self-protection of the producer strains. Saris et al. (1996)
Antonie van Leewenhoek
69:151-159. Moreover, the expression of the lantibiotic genes is usually regulated either by a single transcription regulator (Peschel et al. (1993)
Mol. Microbiol.
9:31-39; Qi et al. (1999)
Appl. Environ. Microbiol.
65:652-658) or by a two-component signal transduction system (de Ruyter et al. (1996)
J. Bacteriol.
178:3434-3439; Klein et al. (1993)
Appl. Environ. Microbiol.
59:296-303; Kuipers et al. (1995) J. Biol. Chem. 270:27295-27304).
Previously, the isolation, biochemical and genetic characterizations of mutacin II, produced by a group II strain of the oral bacteria
Streptococcus mutans
was reported. Chen et al. (1999)
Appl Environ. Microbiol.
65:1356-1360; Novak et al. (1994)
J. Bacteriol.
176:4316-4320; Novak et al. (1996)
Anal Biochem.
236:358-360; Qi et al. (1999)
Appl. Environ. Microbiol.
65:652-658. Mutacin II belongs to subgroup AII in the lantibiotic family. Recently, the isolation and genetic characterization of mutacin III from the group III S. mutans strain UA787 was reported. Qi et al. (1999)
Appl. Environ. Microbiol.
65:3880-3887. The mature mutacin III is twenty-two amino acids in size, and shows striking similarity with another lantibiotic, epidermin, produced by
Staphylococcus epidermidis
. Allgaier et al. (1986)
Eur. J. Biochem.
160:9-22. The mutacin III biosynthesis gene locus consists of eight genes in the order of mutR, -A, -A′; -B, -C, -D, -P, and T. The genomic organization and primary sequence of mutacin III places it in subgroup AI with epidermin and galliderniin as its closest neighbors. Applicants disclosed herein the biochemical and genetic characterization of mutacin I. Comparison of the biosynthesis genes between mutacin I and mutacin III reveal striking similarities as well as important differences.
The cloning and sequencing of the novel mutacin I biosynthetic genes by using information from the conserved sequence derived from several other lantibiotics, and the isolation and purification of mutacin I is disclosed herein and provides a novel group of antibiotics which can be utilized as anti-microbial agents against, for example, presently antibiotic resistant microorganisms.
SUMMARY OF THE INVENTION
According to the present invention, an isolated and purified DNA sequence which encodes a lantibiotic, mutacin I, is disclosed. The nucleic acid sequence is set forth in SEQ ID No: 1 and the amino acid sequence is set forth in SEQ ID No: 2. Also disclosed are pharmaceutical compositions containing mutacin I and methods for their use.
REFERENCES:
patent: 4554101 (1985-11-01), Hopp et al.
patent: 4603102 (1986-07-01), Himmelmann et al.
patent: 4740593 (1988-04-01), Gonzalez et al.
patent: 4980163 (1990-12-01), Blackburn et al.
patent: 5043176 (1991-08-01), Bycroft et al.
patent: 5135910 (1992-08-01), Blackburn et al.
patent: 5932469 (1999-08-01), Hillman
patent: WO92/18143 (1992-10-01), None
patent: WO93/19087 (1993-09-01), None
Augustin et al. (1992), “Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants ofStaphylococcus epidermidis”, Eur. J. Biochem., 204:1149-1154.
Bedwell et al. (1989), “Sequence and Structural Requirements of a Mitochondrial Protein Import Signal Defined by Saturation Cassette Mutagenesis”, Mol.Cell. Biol., 9:1014-1025.
Buchman et al. (1988), “Structure, Expression, and Evolution of a Gene Encoding the Precursor of Nisin, a Small Protein Antibiotic*”, J. Biol. Chem., 263:16260-16266.
Burdett (1990), “Nucleotide sequence of the tet(M) gene of Tn916”, Nucl. Acid Res., 18:6137.
Caufield et a
Caufield Page W.
Chen Ping
Qi Fengxia
Ford Vanessa L.
Gifford, Krass, Groh Sprinkle, Anderson & Citkowski, P.C.
Navarro Mark
The UAB Research Foundation
LandOfFree
Mutacin I biosynthesis genes and proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutacin I biosynthesis genes and proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutacin I biosynthesis genes and proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2828942